Procter & Gamble Health Croissance future
Future contrôle des critères 1/6
Procter & Gamble Health devrait augmenter ses bénéfices et ses revenus de 11.3% et de 8.8% par an respectivement, tandis que le BPA devrait croître de croître de 11.3% par an.
Informations clés
11.3%
Taux de croissance des bénéfices
11.3%
Taux de croissance du BPA
| Pharmaceuticals croissance des bénéfices | 18.0% |
| Taux de croissance des recettes | 8.8% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 06 Nov 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Here's Why Procter & Gamble Health Limited's (NSE:PGHL) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 29
Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00
Nov 15Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)
Nov 05Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Sep 28Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Aug 27Earnings Not Telling The Story For Procter & Gamble Health Limited (NSE:PGHL)
Jun 08Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 6/30/2026 | 13,536 | 2,650 | N/A | N/A | 1 |
| 6/30/2025 | 12,546 | 2,376 | N/A | N/A | 1 |
| 9/30/2024 | 11,597 | 2,177 | N/A | N/A | N/A |
| 6/30/2024 | 11,513 | 2,010 | 2,066 | 2,283 | N/A |
| 3/31/2024 | 11,686 | 2,140 | N/A | N/A | N/A |
| 12/31/2023 | 12,370 | 2,267 | 1,527 | 1,740 | N/A |
| 9/30/2023 | 12,370 | 2,314 | N/A | N/A | N/A |
| 6/30/2023 | 12,296 | 2,295 | 1,935 | 2,360 | N/A |
| 3/31/2023 | 12,243 | 2,408 | N/A | N/A | N/A |
| 12/31/2022 | 11,712 | 2,328 | 2,718 | 3,349 | N/A |
| 9/30/2022 | 11,392 | 2,008 | N/A | N/A | N/A |
| 6/30/2022 | 11,144 | 1,925 | 1,316 | 1,695 | N/A |
| 3/31/2022 | 11,039 | 1,853 | N/A | N/A | N/A |
| 12/31/2021 | 10,552 | 1,499 | 816 | 1,157 | N/A |
| 9/30/2021 | 10,176 | 1,729 | N/A | N/A | N/A |
| 6/30/2021 | 10,087 | 1,768 | 1,947 | 2,473 | N/A |
| 3/31/2021 | 9,219 | 1,884 | N/A | N/A | N/A |
| 12/31/2020 | 9,308 | 2,191 | N/A | N/A | N/A |
| 9/30/2020 | 9,274 | 1,894 | N/A | N/A | N/A |
| 6/30/2020 | 8,886 | 1,659 | 1,414 | 1,569 | N/A |
| 3/31/2020 | 9,237 | 1,645 | N/A | N/A | N/A |
| 12/31/2019 | 9,266 | 1,588 | 1,512 | 1,619 | N/A |
| 9/30/2019 | 8,942 | 1,340 | N/A | N/A | N/A |
| 6/30/2019 | 8,952 | 1,394 | N/A | N/A | N/A |
| 3/31/2019 | 8,819 | 1,281 | N/A | N/A | N/A |
| 12/31/2018 | 8,490 | 1,017 | -1,571 | -1,304 | N/A |
| 9/30/2018 | 12,290 | 1,349 | N/A | N/A | N/A |
| 6/30/2018 | 12,087 | 1,140 | N/A | N/A | N/A |
| 3/31/2018 | 11,762 | 1,018 | N/A | N/A | N/A |
| 12/31/2017 | 6,981 | 610 | N/A | 537 | N/A |
| 9/30/2017 | 10,523 | 828 | N/A | N/A | N/A |
| 6/30/2017 | 10,088 | 797 | N/A | N/A | N/A |
| 3/31/2017 | 10,177 | 823 | N/A | N/A | N/A |
| 12/31/2016 | 9,926 | 791 | N/A | 1,070 | N/A |
| 9/30/2016 | 9,810 | 723 | N/A | N/A | N/A |
| 6/30/2016 | 9,681 | 572 | N/A | N/A | N/A |
| 3/31/2016 | 9,589 | 562 | N/A | N/A | N/A |
| 12/31/2015 | 9,383 | 536 | N/A | 835 | N/A |
| 9/30/2015 | 9,148 | 401 | N/A | N/A | N/A |
| 6/30/2015 | 8,798 | 451 | N/A | N/A | N/A |
| 3/31/2015 | 8,712 | 493 | N/A | N/A | N/A |
| 12/31/2014 | 8,662 | 432 | N/A | 50 | N/A |
| 9/30/2014 | 8,544 | 516 | N/A | N/A | N/A |
| 6/30/2014 | 8,409 | 498 | N/A | N/A | N/A |
| 3/31/2014 | 8,082 | 455 | N/A | N/A | N/A |
| 12/31/2013 | 7,965 | 559 | N/A | 5 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de PGHL ( 11.3% par an) est supérieure au taux d'épargne ( 6.7% ).
Bénéfices vs marché: Les bénéfices de PGHL ( 11.3% par an) devraient croître plus lentement que le marché Indian ( 18% par an).
Croissance élevée des bénéfices: Les bénéfices de PGHL devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de PGHL ( 8.8% par an) devrait croître plus lentement que le marché de Indian ( 10.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de PGHL ( 8.8% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de PGHL devrait être élevé dans 3 ans